Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study

BACKGROUND: Influenza causes substantial morbidity and mortality despite available treatments. Anecdotal reports suggest that plasma with high antibody titres to influenza might be of benefit in the treatment of severe influenza. METHODS: In this randomised, open-label, multicentre, phase 2 trial, 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Beigel, John H, Tebas, Pablo, Elie-Turenne, Marie-Carmelle, Bajwa, Ednan, Bell, Todd E, Cairns, Charles B, Shoham, Shmuel, Deville, Jaime G, Feucht, Eric, Feinberg, Judith, Luke, Thomas, Raviprakash, Kanakatte, Danko, Janine, O'Neil, Dorothy, Metcalf, Julia A, King, Karen, Burgess, Timothy H, Aga, Evgenia, Lane, H Clifford, Hughes, Michael D, Davey, Richard T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828518/
https://www.ncbi.nlm.nih.gov/pubmed/28522352
http://dx.doi.org/10.1016/S2213-2600(17)30174-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828518/
https://www.ncbi.nlm.nih.gov/pubmed/28522352
http://dx.doi.org/10.1016/S2213-2600(17)30174-1

Ejemplares similares